Cinclus Pharma Financial Flexibility Index
Cinclus Pharma financial flexibility index. Cinclus Pharma (CINPHA) has a Financial Flexibility Index of -0.39x as of June 2026. Free cash flow of Skr-86.19 Million (operating CF Skr-86.19 Million minus capex Skr0.00) represents 0% of total liabilities (Skr221.84 Million). See cash generation quality of Cinclus Pharma to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Cinclus Pharma (2022–2025)
Financial flexibility index of Cinclus Pharma from 2022 to 2025. Historical Financial Flexibility Index trend for Cinclus Pharma across 4 annual periods. Explore CINPHA debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Cinclus Pharma Financial Flexibility Index by Year (2022–2025)
Cinclus Pharma financial flexibility index by year from 2022 to 2025. Year-by-year free cash flow to debt coverage for Cinclus Pharma. For the full cash flow conversion analysis, see CINPHA cash flow metrics.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.41x | Skr-73.51 Million | Skr-74.65 Million | Skr177.16 Million | ▲ +89.4% |
| 2024 | -3.90x | Skr-178.37 Million | Skr-178.37 Million | Skr45.68 Million | ▼ -219.6% |
| 2023 | -1.22x | Skr-209.19 Million | Skr-209.19 Million | Skr171.21 Million | ▲ +62.5% |
| 2022 | -3.26x | Skr-192.08 Million | Skr-192.08 Million | Skr58.90 Million | — |